Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study
Michael Pavlides, Yasaman Vali, Ferenc E. Mózes, Kristy Wonders et autres
2 citationsNature Medicine
Jérémy Magnanensi
Informations fournies par OpenAlex. Research Africa ne déduit ni nationalité, ni poste, ni coordonnées personnelles.
38Publications signalées
663Citations signalées
1Affiliations récentes
Institutions déclarées
Domaines associés
Liver Disease Diagnosis and TreatmentSpectroscopy and Chemometric AnalysesLiver Disease and TransplantationWater Quality Monitoring and AnalysisDiabetes, Cardiovascular Risks, and Lipoproteins
Publications récentes
Prospective validation of imaging and serum diagnostic biomarkers of steatohepatitis and fibrosis in MASLD: the LITMUS Imaging Study.
Michael Pavlides, Yasaman Vali, Ferenc E. Mózes, Kristy Wonders et autres
0 citationsOpen Access CRIS of the University of Bern
SAT-468 Clinical impact of bacterial infections in acutely decompensated cirrhosis: insights from 4.97 million admissions
Javier Fernández, Yacine Hajji, Jonel Trebicka, Thierry Artzner et autres
0 citationsJournal of Hepatology
TOP-032 Real-world data highlight gaps in hospital care and access to gastroenterologists or hepatologists in patients with acutely decompensated cirrhosis
Jonel Trebicka, Bérénice Alard, Thierry Artzner, William Bernal et autres
0 citationsJournal of Hepatology
WED-499 Closing the coding gap: International classification of diseases (ICD)-10 code K76.82 for hepatic encephalopathy achieves rapid uptake in U.S. real-world practice
Dominique Thabut, P Ricci, Bérénice Alard, Maxime Anné et autres
0 citationsJournal of Hepatology
SAT-478 Use and effectiveness of lactulose and rifaximin in patients with cirrhosis and hepatic encephalopathy highlight need for new treatments: insights from real-world data
Jacqueline O'Leary, Jonel Trebicka, Jennifer Jara Vargas, Jérémy Magnanensi et autres
0 citationsJournal of Hepatology
Serial measurements of NIS2+® enable monitoring disease evolution in patients with MASH: A retrospective cohort analysis
Arun J. Sanyal, Vlad Ratziu, Yacine Hajji, Jérémy Magnanensi et autres
1 citationHepatology Communications
WED-494 Development and validation of two NIS2+®-based models for the detection of MASH resolution and fibrosis improvement
Vlad Ratziu, Sven Francque, Yacine Hajji, Jérémy Magnanensi et autres
0 citationsJournal of Hepatology
OS-013 Optimizing non-invasive screening to reduce biopsy screen failure in clinical trials for metabolic dysfunction-associated steatotic liver disease
Yasaman Vali, Kristy Wonders, Guruprasad P. Aithal, R. Aller et autres
0 citationsJournal of Hepatology
GS-001 Diagnostic performance of imaging and serum based MASLD biomarkers: robust validation in the prospective LITMUS imaging study
Michael Pavlides, Yasaman Vali, Ferenc E. Mózes, Kristy Wonders et autres
4 citationsJournal of Hepatology
FRI-172 Intraperitoneal administration of investigational drug VS-01 captures accumulated metabolites in patients with acutely decompensated liver cirrhosis
Olaf Tyc, Bérénice Alard, Meriam Kabbaj, Jérémy Magnanensi et autres
0 citationsJournal of Hepatology
TOP-394 Comprehensive analysis of biomarker performance targeting “advanced fibrosis” and “at-risk” metabolic-dysfunction associated steatotic liver disease (MASH) – primary analysis of the LITMUS study cohort
Yasaman Vali, Kristy Wonders, Guruprasad P. Aithal, R. Aller et autres
0 citationsJournal of Hepatology
BNTIC News n’est pas le producteur de ces données. Recherche à la demande dans Crossref et Europe PMC, sans clé ; OpenAlex reste optionnel. Aucun service payant requis, aucune réponse conservée. Sources et limites.